Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 2.748E-06 | 3.325E-03 | CA2, CA7 |
BP | GO:0065007; biological regulation | GO:0035625; epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway | 5.494E-06 | 4.785E-03 | ADRA2A, ADRA2C |
BP | GO:0009987; cellular process | GO:0032811; negative regulation of epinephrine secretion | 5.494E-06 | 4.785E-03 | ADRA2A, ADRA2C |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 2.741E-17 | 1.989E-13 | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 2.082E-15 | 9.068E-12 | CA1, CA12, CA2, CA4, CA6, CA7, CA9 |
CC | GO:0044464; cell part | GO:0030424; axon | 4.004E-06 | 4.151E-03 | ADRA2C, APP, CA2, MAPK1, MAPT |
MF | GO:0060089; molecular transducer activity | GO:0004938; alpha2-adrenergic receptor activity | 2.748E-06 | 3.325E-03 | ADRA2A, ADRA2C |
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 7.370E-06 | 6.172E-03 | CA1, CA12, CA2, CA4, CA6, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 1.372E-05 | 9.335E-03 | CA1, CA2 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.010E-21 | 2.199E-17 | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00040 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 5.284E-04 | 7.775E-03 | AKR1B10; AKR1B1 |
hsa00051 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 4.170E-04 | 7.775E-03 | AKR1B10; AKR1B1 |
hsa00052 | Galactose metabolism_Homo sapiens_hsa00052 | 2.904E-06 | 1.495E-04 | AKR1B10; GAA; AKR1B1 |
hsa00561 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.417E-03 | 1.824E-02 | AKR1B10; AKR1B1 |
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.885E-21 | 2.972E-19 | CA12; CA1; CA2; CA4; CA7; CA6; CA9; CA14 |
hsa04022 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 5.022E-04 | 7.775E-03 | MAPK1; ADRA2C; ADRA2A |
hsa04080 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.161E-03 | 2.473E-02 | NMUR2; ADRA2C; ADRA2A |
hsa04725 | Cholinergic synapse_Homo sapiens_hsa04725 | 4.908E-03 | 4.676E-02 | ACHE; MAPK1 |
hsa04726 | Serotonergic synapse_Homo sapiens_hsa04726 | 4.994E-03 | 4.676E-02 | APP; MAPK1 |
hsa04964 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.138E-04 | 7.339E-03 | CA2; CA4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Pediculus humanus capitis | B85.0 | ACHE |
A00-B99: Certain infectious and parasitic diseases | Helminth infection | A00-B99 | ACHE |
C00-D49: Neoplasms | Renal cancer | C64 | CA9 |
C00-D49: Neoplasms | Cancer | C00-C96 | CA1; CA9; MAPK1; APP; ACHE |
C00-D49: Neoplasms | Breast cancer | C50 | CA9 |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9 |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9; MAPK1 |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9 |
C00-D49: Neoplasms | Glioma | C71 | APP |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | AKR1B1 |